Avecho Biotechnology Ltd: Appendix 4D and Half-year Financial Report

Aug 26 09:22 · Announcements

Avecho Biotechnology Doses First Patient in Phase III Anti-Insomnia Drug Trial

MT NewswiresMay 16 09:42

Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial

MT NewswiresMar 26 06:37

Avecho to Push Forward With Phase III Trial of Anti-Insomnia Drug

MT NewswiresMar 14 19:41

Avecho Biotechnology Secures Ethics Clearance for Phase Three Insomnia Trial

MT NewswiresMar 7 14:11

We're Not Very Worried About Avecho Biotechnology's (ASX:AVE) Cash Burn Rate

Yahoo FinanceJan 13, 2023 07:04